Skip to main content
. 2018 Apr 26;62(5):e02360-17. doi: 10.1128/AAC.02360-17

TABLE 1.

Baseline characteristics of patients infected with M. abscessus belonging to CLA-resistant and -sensitive genotypes

Characteristica Valueb
P value
CLA-resistant group (n = 69) CLA-sensitive group (n = 31)
Median age (IQR) (yr) 58 (44–66) 56 (32–64) 0.562
Males 26 (37.7) 17 (54.8) 0.107
BMI (mean ± SD) (kg/m2) 19.93 ± 0.37 19.69 ± 0.57 0.729
Underlying disease
    Prior tuberculosisc 29 (42.0) 16 (51.6) 0.373
    COPD 1 (1.4) 2 (6.5) 0.226
    Hypertension 11 (15.9) 3 (9.7) 0.601
    Diabetes 2 (2.9) 4 (12.9) 0.135
    CHD 4 (5.8) 0 (0) 0.414
    Malignancy 3 (4.3) 0 (0) 0.550
History of surgery 3 (4.3) 1 (3.2) 1
Symptoms
    Cough 55 (79.7) 25 (80.6) 0.914
    Sputum 69 (100.0) 31 (100.0) 1
    Fever 15 (21.7) 4 (12.9) 0.298
    Hemoptysis 22 (31.9) 4 (12.9) 0.045
Radiographic features
    Extent 0.404
        Bilateral involvement 58 (84.0) 28 (90.3)
        Unilateral involvement 11 (15.9) 3 (9.7)
    Median no. of lobes (IQR) 4 (3–6) 4 (2–6) 0.419
    Disease pattern
        Bronchiectasis 66 (95.7) 29 (93.4) 0.655
        Cavity 50 (72.5) 8 (25.8) <0.001
        Nodules (diam < 1 cm) 38 (55.0) 19 (61.3) 0.561
        Nodules (diam > 1 cm) 39 (56.5) 16 (51.6) 0.648
        Tree-in-bud pattern 16 (23.2) 14 (45.2) 0.027
Initial AFB smear positivity 28 (40.6) 10 (32.3) 0.428
Initial morphotype 0.770
    Rough 40 (58.0) 17 (54.8)
    Smooth 29 (42.0) 14 (45.2)
a

COPD, chronic obstructive pulmonary disease; CHD, coronary heart disease; AFB, acid-fast bacilli; IQR, interquartile range.

b

Data are the numbers (%) of patients found in the CLA-resistant and -sensitive genotype groups unless otherwise indicated.

c

Patients treated for tuberculosis prior to the diagnosis of M. abscessus lung disease.